Brought to you by 
BMS sells medical imaging unit to equity firm Avista for $525mm
01 Jun 2016
Executive Summary
Only a few days after buying Boston Scientific's fluid management and venous access businesses, private equity company Avista Capital Partners is making another medtech purchase, this time Bristol-Myers Squibb Medical Imaging (BMS MI) for $525mm in cash. The sale is part of BMS's corporate-wide restructuring announced earlier this month.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
Deal Status
- Final
Deal Type
-
Acquisition
- Buy-out
- Divestiture/Spin-Out
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
BMS sells medical imaging unit to equity firm Avista for $525mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice